Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 1 7Phase 3 4Phase 1/2 3Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 40Recruiting 25Terminated 19Active not recruiting 11Unknown 5Not yet recruiting 4Withdrawn 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 2

Conditions

Mesothelioma 2Neoplasm Metastasis 1Mesothelioma, Malignant 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 28pembrolizumab 22Bevacizumab 18Fluorouracil 17Cisplatin 17Nivolumab 16Capecitabine 16Leucovorin 15Dexamethasone 14Carboplatin 13avelumab 12Oxaliplatin 12Radiosurgery 11Gemcitabine 11Rituximab 10Radiotherapy 10Lenalidomide 10ALT-803 10venetoclax 9fludarabine 9Taxes 9Omacor 9Azacitidine 9130-nm albumin-bound paclitaxel 9Paclitaxel 8Docetaxel 8Bortezomib 8fludarabine phosphate 7Melphalan 7Irinotecan 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Withdrawn × Pemetrexed × Clear all
NCT04430933 2021-08-18

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

NextCure, Inc.

Phase 1/2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00668499 2014-05-21

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

University of Southern California

Phase 1/2 Withdrawn
Other solid neoplasmThoracic

Mesothelioma

NCT01353482 2012-03-22

MESO-02

University College, London

Phase 1/2 Withdrawn
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡